US2007191281A1PendingUtilityA1

Compound containing a labile disulfide bond

52
Assignee: WOLFF JON APriority: May 16, 1998Filed: Oct 12, 2005Published: Aug 16, 2007
Est. expiryMay 16, 2018(expired)· nominal 20-yr term from priority
C07C 323/62A61K 48/00A61K 31/155C07H 21/04A61K 31/198C07C 323/60C07D 207/46A61K 38/08
52
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A labile disulfide-containing compound under physiological conditions containing a labile disulfide bond and a transduction signal.

Claims

exact text as granted — not AI-modified
1 . A process for delivering a compound having a labile disulfide bond into a mammal, comprising: 
 a) forming the compound having a disulfide bond selected from the group consisting of (i) a disulfide bond that is cleaved more rapidly than oxidized glutathione, and (ii) a disulfide bond constructed from thiols in which one of the constituent thiols has a lower pKa than glutathione, and (iii) a disulfide bond that is activated by intramolecular attack from a free thiol;    b) attaching a transduction signal to the compound;    c) inserting the compound into the mammal; and,    d) releasing the bond between the sulfur atoms in the disulfide.    
     
     
         2 . The process of  claim 1  wherein the transduction signal consists essentially of SEQ ID 1.  
     
     
         3 . The process of  claim 1  wherein the transduction signal consists of VP22.  
     
     
         4 . The process of  claim 1  wherein the transduction signal consists of ANTP.  
     
     
         5 . The process of  claim 1  wherein the transduction signal consists of a peptide containing a cationic residues.  
     
     
         6 . The process of  claim 1  wherein the transduction signal consists of a polymer containing a plurality of guanidinium groups.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.